ORIGINAL RESEARCH
Accepted on 04 Jul 2025
Dual PI3K/mTOR inhibitor NVP-BEZ235 induces cell cycle arrest via autophagy mediated protein degradation of RPL19 in Nephroblastoma cell
doi 10.3389/fphar.2025.1588722
- 253 views
- Frontiers in Medicine
- Translational Medicine
- Research Topics
- The Molecular Mechanisms and Therapeutic Implications of Protein Kinase Inhibitors in Cancer Therapy
The Molecular Mechanisms and Therapeutic Implications of Protein Kinase Inhibitors in Cancer Therapy
2,447
Total downloads
9,792
Total views and downloads
Submit your idea
You will be redirected to our submission process.
Articles
REVIEW
Published on 19 Jun 2025
PLK1 in cancer therapy: a comprehensive review of immunomodulatory mechanisms and therapeutic opportunities
doi 10.3389/fimmu.2025.1602752
- 938 views
PERSPECTIVE
Published on 05 Dec 2024
Clinical perspectives on the value of testing for STK11 and KEAP1 mutations in advanced NSCLC
doi 10.3389/fonc.2024.1459737
- 2,121 views
- 1 citation
ORIGINAL RESEARCH
Published on 20 Nov 2024
COVID-19 mitigates the response to TKIs in patients with CML via the inhibition of T-cell immunity
doi 10.3389/fimmu.2024.1452035
- 1,223 views
ORIGINAL RESEARCH
Published on 01 Nov 2024
The enhancement of immunoactivity induced by immunogenic cell death through serine/threonine kinase 10 inhibition: a potential therapeutic strategy
doi 10.3389/fimmu.2024.1451796
- 1,477 views
REVIEW
Published on 12 Aug 2024
Biological functions and therapeutic potential of CKS2 in human cancer
doi 10.3389/fonc.2024.1424569
- 1,228 views
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
You will be redirected to our submission process.